切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2021, Vol. 10 ›› Issue (02) : 191 -196. doi: 10.3877/cma.j.issn.2095-3232.2021.02.015

所属专题: 文献

临床研究

ICG"四区三相"荧光显像法在机器人解剖性肝切除术中的应用
张修平1, 徐帅2, 赵之明1, 刘荣2,()   
  1. 1. 100853 北京,解放军总医院第一医学中心肝胆胰外科医学部
    2. 100853 北京,解放军总医院第一医学中心肝胆胰外科医学部;300071 天津,南开大学医学院
  • 收稿日期:2020-12-26 出版日期:2021-04-10
  • 通信作者: 刘荣

Application of ICG "four-zone three-phase" fluorescence imaging in robot-assisted anatomical hepatectomy

Xiuping Zhang1, Shuai Xu2, Zhiming Zhao1, Rong Liu2,()   

  1. 1. Medical Department of Hepatobiliary and Pancreatic Surgery, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
    2. Medical Department of Hepatobiliary and Pancreatic Surgery, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China; School of Medicine, Nankai University, Tianjin 300071, China
  • Received:2020-12-26 Published:2021-04-10
  • Corresponding author: Rong Liu
引用本文:

张修平, 徐帅, 赵之明, 刘荣. ICG"四区三相"荧光显像法在机器人解剖性肝切除术中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2021, 10(02): 191-196.

Xiuping Zhang, Shuai Xu, Zhiming Zhao, Rong Liu. Application of ICG "four-zone three-phase" fluorescence imaging in robot-assisted anatomical hepatectomy[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2021, 10(02): 191-196.

目的

探讨ICG"四区三相"荧光显像法在机器人解剖性肝切除术中的应用价值。

方法

回顾性分析2019年1月至2019年6月解放军总医院第一医学中心采用ICG"四区三相"荧光显像法行机器人解剖性肝切除术的36例患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男30例,女6例;平均年龄(52±9)岁。采用达芬奇机器人手术系统,通过ICG荧光显像技术结合术中超声探查肿瘤的位置及大小。超声刀和Ligasure等能量器械自下而上、自前向后分层离断肝实质。

结果

所有患者均顺利完成机器人解剖性肝切除。手术时间中位数130(30~250)min,术中出血量120(30~350)ml。术中通过ICG荧光显像联合超声发现隐匿的可疑肿瘤病灶7个,经术中病理检查显示肝细胞癌3个,肝硬化结节3个,肝组织炎性改变1个。术前影像学诊断肿瘤经术后病理检查显示,肝细胞癌34个,胆管细胞癌2个,均为R0切除。ICG荧光显像将肝脏分为4个解剖区域——"肿瘤区"、"瘤周区"、"缺血区"及"预留肝脏区",机器人腔镜手术系统可将ICG荧光显像中正常相、荧光相、融合相同时显示在主屏幕。

结论

ICG"四区三相"荧光显像法作为一种术中实时导航方法,能精确定位大部分肿瘤,实时清晰显示断肝平面,实现解剖性肝切除的精准化和规范化。

Objective

To evaluate the application of ICG "four-zone three-phase" fluorescence imaging in robot-assisted anatomical hepatectomy.

Methods

Clinical data of 36 patients who underwent robot-assisted anatomical hepatectomy using ICG "four-zone three-phase" fluorescence imaging from January to June 2019 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 30 patients were male and 6 female, aged (52±9) years on average. Using da Vinci robot-assisted surgery system, the tumor location and size were detected by ICG fluorescence imaging technology combined with intraoperative ultrasound. The liver parenchyma was separated and resected layer-by-layer from bottom to top and front to back by using CUSA, Ligasure and other energy instruments.

Results

All the patients completed robot-assisted anatomical hepatectomy successfully. The median operation time was 130 (30-250) min and intraoperative blood loss was 120(30-350) ml. Intraoperative ICG fluorescence imaging combined with ultrasound found 7 suspicious invisible tumor lesions, of which 3 lesions were diagnosed as hepatocellular carcinoma by intraoperative pathological examination, 3 cirrhosis nodules and 1 inflammatory change. 34 lesions were diagnosed as hepatocellular carcinoma and 2 cholangiocarcinoma by preoperative imaging diagnosis combined with postoperative pathological examination, and all underwent R0 resection. According to ICG fluorescence imaging, the liver was divided into 4 anatomical zones including "tumor zone", "peritumor zone", "ischemia zone" and "reserved liver zone". The normal phase, fluorescence phase and fusion phase of ICG fluorescence imaging could be simultaneously displayed on the main screen by the robot-assisted endoscopic surgery system.

Conclusions

As a real-time intraoperative navigation method, ICG "four-zone three-phase" fluorescence imaging can accurately locate most tumors, clearly display the liver resection plane in a real-time manner and achieve the precision and standardization of anatomical hepatectomy.

图1 一例肝癌患者术前及术中注射ICG后肝脏融合荧光显像
图2 一例达芬奇机器人肝切除术中ICG荧光显像联合超声检查发现可疑肿瘤病灶
图3 离体肿瘤剖面荧光显像(黑白模式)
[1]
Liu Z, Mao X, Jiang Y, et al. Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China[J]. Cancer Med, 2019, 8(12):5787-5799.
[2]
方驰华,张鹏,罗火灵,等. 增强现实导航技术联合吲哚菁绿分子荧光影像在三维腹腔镜肝切除术中的应用[J]. 中华外科杂志,2019,57(8):578-584.
[3]
Nguyen KT, Gamblin TC, Geller DA. World review of laparoscopic liver resection-2,804 patients[J]. Ann Surg, 2009, 250(5):831-841.
[4]
索晓鹏,田远虎,张克明. 吲哚菁绿荧光导航用于腹腔镜肝胆手术的研究进展[J]. 中国微创外科杂志,2020,20(5):455-458,462.
[5]
Chen J, Huang K, Wu J, et al. Survival after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis[J]. Dig Dis Sci, 2011, 56(6):1626-1633.
[6]
刘煜,代扬,张欣雪,等. 单发小肝癌合并微血管侵犯解剖性与非解剖性肝切除疗效对比分析[J]. 中华医学杂志,2018,98(24):1937-1940.
[7]
Marino MV, Ramirez SB, Ruiz MG. The application of indocyanine green (ICG) staining technique during robotic-assisted right hepatectomy: with video[J]. J Gastrointest Surg, 2019, 23(11):2312-2313.
[8]
陈琳,罗鸿萍,朱鹏,等. 吲哚菁绿荧光实时成像技术在机器人肝切除中的初步应用(附二例报告)[J]. 腹部外科,2017,30(4):254-257.
[9]
刘荣,尹注增,赵之明,等. 应用机器人手术系统行肝胆胰手术单中心1 000例报告[J]. 中国实用外科杂志,2017,37(3):288-290.
[10]
张树庚,刘连新. 吲哚菁绿荧光融合影像引导技术在腹腔镜肝切除中的应用及展望[J]. 中华肝胆外科杂志,2019,25(2):129-131.
[11]
Ishizawa T, Masuda K, Urano Y, et al. Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma[J]. Ann Surg Oncol, 2014, 21(2):440-448.
[12]
Gravetz A, Sucandy I, Wilfong C, et al. Single-institution early experience and learning curve with robotic liver resections[J]. Am Surg, 2019, 85(1):115-119.
[13]
Tsilimigras DI, Moris D, Vagios S, et al. Safety and oncologic outcomes of robotic liver resections: a systematic review[J]. J Surg Oncol, 2018, 117(7):1517-1530.
[14]
刘胜,尹新民,刘毅,等. ICG荧光显影引导腹腔镜解剖性右半肝切除治疗肝脏肿瘤安全性及可行性研究[J]. 中国实用外科杂志,2019,39(9):944-948.
[15]
Gotoh K, Yamada T, Ishikawa O, et al. A novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation[J]. J Surg Oncol, 2009, 100(1):75-79.
[16]
Liu Y, Zhao YM, Akers W, et al. First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of near-infrared fluorescent imaging agent:a pilot study[J]. Transl Res, 2013, 162(5):324-331.
[17]
Lim C, Vibert E, Azoulay D, et al. Indocyanine green fluorescence imaging in the surgical management of liver cancers: current facts and future implications[J]. J Visc Surg, 2014, 151(2):117-124.
[18]
Kokudo N, Ishizawa T. Clinical application of fluorescence imaging of liver cancer using indocyanine green[J]. Liver Cancer, 2012, 1(1):15-21.
[19]
中国研究型医院学会微创外科学专业委员会. 吲哚菁绿荧光染色在腹腔镜肝切除术中应用的专家共识[J]. 腹腔镜外科杂志,2019,24(5):388-394.
[20]
Kudo H, Ishizawa T, Tani K, et al. Visualization of subcapsular hepatic malignancy by indocyanine-green fluorescence imaging during laparoscopic hepatectomy[J]. Surg Endosc, 2014, 28(8): 2504-2508.
[1] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[2] 王振宁, 杨康, 王得晨, 邹敏, 归明彬, 王雅楠, 徐明. 机器人与腹腔镜手术联合经自然腔道取标本对中低位直肠癌患者远期疗效比较[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 437-442.
[3] 钟锴, 蒋铁民, 张瑞青, 吐尔干艾力·阿吉, 邵英梅, 郭强. 加速康复外科在肝囊型棘球蚴病肝切除术中的应用分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 425-429.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[6] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[7] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[8] 王兴, 文阳辉, 姚戈冰, 郭平学, 杨自华. ICG荧光腹腔镜下胆囊切除术的临床应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 663-666.
[9] 施一辉, 张平新, 朱勇, 杨德林. 机器人辅助前列腺根治术后切缘阳性的研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 633-637.
[10] 庞名扬, 魏勇, 沈露明, 朱清毅. 运用国产单孔机器人完成经膀胱入路膀胱部分切除术治疗膀胱癌一例报道[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 638-643.
[11] 王岩, 钱宏阳, 朱寅杰, 董柏君, 潘家骅, 薛蔚. 机器人辅助单孔腹膜外根治性前列腺切除治疗高危前列腺癌的瘤控效果初探[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 435-440.
[12] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
[13] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[14] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[15] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?